RARE - Ultragenyx Pharmaceutical Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - RARE (1515673)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
31 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S29+1+2-4-10

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-08-28
RAREKakkis Emil DPres, CEOP - Purchase$52.52+7,5002,990,3100%+$393,922
2017-05-26
RAREHuizenga Theodore AlanVP, Controller, PAOS - Sale$57.46-4809,366-5%-$27,581
2017-03-09
RAREHuizenga Theodore AlanController, PAOS - Sale$86.34-2,5009,709-20%-$215,845-20-31
D
2017-03-02
RARESharp ShaliniCFO, EVPS - Sale+OE$90.10-12,00055,887-18%-$1,081,176-1-2-24
D
2016-12-05
RAREAliski WilliamDirS - Sale+OE$78.19-6,00059,985-9%-$469,1600-8-2
D
2016-11-16
RAREHuizenga Theodore AlanController, PAOS - Sale+OE$79.73-2,00011,134-15%-$159,460+2+5-14
A
2015-06-17
RAREHuizenga Theodore AlanController, PAOS - Sale$94.80-1,5004,300-26%-$142,200+2+5-14
2016-11-15
RAREKakkis Emil DPres, CEOS - Sale$81.29-20,0002,999,388-1%-$1,625,753+2+6-12
D
2016-11-09
RARESharp ShaliniCFO, EVPS - Sale+OE$71.20-24,00045,387-35%-$1,708,894+10+9-1-19
D
2016-10-19
RARESharp ShaliniCFO, SVPS - Sale+OE$61.40-12,00045,387-21%-$736,820-1-5+25-8
2016-10-14
RAREKakkis Emil DPres, CEOS - Sale$63.02-20,0003,019,388-1%-$1,260,360-1+6+32-2
2016-08-15
RAREKakkis Emil DPres, CEOS - Sale$67.61-20,0003,039,388-1%-$1,352,251+1+7+14+18
2016-07-21
RAREAgarwal SunilChief Medical OfficerS - Sale$52.68-6499,528-6%-$34,189+3+17+26+33
2016-07-15
RAREKakkis Emil DPres, CEOS - Sale$50.85-20,0003,059,388-1%-$1,016,909+4+7+28+35
2016-06-20
RAREAgarwal SunilChief Medical OfficerS - Sale$54.16-65010,569-6%-$35,204+1-9+1+37
2016-05-24
RAREAgarwal SunilChief Medical OfficerS - Sale$66.00-6507,111-8%-$42,900-1+6-30+16
2016-05-16
RAREKakkis Emil DPres, CEOS - Sale$59.95-20,0003,069,760-1%-$1,199,095-3+9-6+31
2016-04-20
RAREAgarwal SunilChief Medical OfficerS - Sale$70.53-6498,567-7%-$45,774+1-8-20-19
2016-04-15
RAREKakkis Emil DPres, CEOS - Sale$70.33-20,0003,089,760-1%-$1,406,554+1+5-15-11
2016-03-22
RAREAgarwal SunilChief Medical OfficerS - Sale$61.45-6509,608-6%-$39,943-4+7+29+25
2016-02-22
RAREAgarwal SunilChief Medical OfficerS - Sale$63.48-65810,650-6%-$41,770+30+3+8
2016-01-20
RAREAgarwal SunilChief Medical OfficerS - Sale$72.83-58512,190-5%-$42,606+1-13-15-28
M
2015-12-30
RAREKakkis Emil DPres, CEOS - Sale$114.53-20,0003,127,881-1%-$2,290,491-3-14-36-45
2015-12-22
RAREAgarwal SunilChief Medical OfficerS - Sale$114.81-49813,231-4%-$57,1750-2-36-57
D
2015-12-18
RAREHuizenga Theodore AlanController, PAOS - Sale+OE$110.55-1,5002,500-38%-$165,825+3+4-29-50
D
2015-12-10
RARESharp ShaliniCFO, SVPS - Sale+OE$101.66-12,00041,801-22%-$1,219,957+3+8-26-42
2015-11-30
RAREKakkis Emil DPres, CEOS - Sale$98.27-20,0003,147,881-1%-$1,965,427-3+6+13-24
2015-11-23
RAREAgarwal SunilChief Medical OfficerS - Sale$95.88-49813,775-3%-$47,748+1+8+20-26
2015-10-30
RAREKakkis Emil DPres, CEOS - Sale$99.57-20,0003,167,881-1%-$1,991,407-1-7-10-42
2015-10-20
RAREAgarwal SunilChief Medical OfficerS - Sale$85.51-64914,817-4%-$55,496+4+17+20-14
2015-09-22
RAREAgarwal SunilChief Medical OfficerS - Sale$109.51-49815,858-3%-$54,536-7-5-10-40

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top